FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+12.43%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$27.2B
AUM Growth
+$1.69B
(+6.6%)
Cap. Flow
-$815M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
550
New
72
Increased
170
Reduced
177
Closed
71
Top Buys
| 1 |
UnitedHealth
UNH
|
$170M |
| 2 |
JPMorgan Chase
JPM
|
$131M |
| 3 |
Qualcomm
QCOM
|
$121M |
| 4 |
Fiserv
FI
|
$110M |
| 5 |
VeriSign
VRSN
|
$110M |
Top Sells
| 1 |
Amazon
AMZN
|
$393M |
| 2 |
Microsoft
MSFT
|
$306M |
| 3 |
Abbott
ABT
|
$163M |
| 4 |
Home Depot
HD
|
$161M |
| 5 |
AGN
Allergan plc
AGN
|
$146M |
Sector Composition
| 1 | Technology | 32.58% |
| 2 | Healthcare | 21.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
iShares Russell 2000 Growth ETF
IWO
$12.5B
| $3.75M | 0.01% |
+17,515
| New | +$3.75M |
|
|
TPTX
252
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $3.75M | 0.01% |
60,138
+10,138
| +20% | +$631K |
|
253
Phreesia
PHR
$1.68B
| $3.74M | 0.01% |
140,330
+43,824
| +45% | +$1.17M |
|
254
Johnson & Johnson
JNJ
$430B
| $3.71M | 0.01% |
25,449
| – | – |
|
255
Lincoln Electric
LECO
$13.5B
| $3.7M | 0.01% |
38,194
+11,609
| +44% | +$1.12M |
|
256
Verizon
VZ
$187B
| $3.65M | 0.01% |
59,517
| – | – |
|
257
Eli Lilly
LLY
$652B
| $3.51M | 0.01% |
26,713
+11,880
| +80% | +$1.56M |
|
258
Humana
HUM
$37B
| $3.48M | 0.01% |
9,495
+2,001
| +27% | +$733K |
|
259
Levi Strauss
LEVI
$8.79B
| $3.48M | 0.01% |
180,146
-826,686
| -82% | -$15.9M |
|
260
Chipotle Mexican Grill
CMG
$55.1B
| $3.41M | 0.01% |
+203,350
| New | +$3.41M |
|
|
AZUL
261
DELISTED
Azul
AZUL
| $3.33M | 0.01% |
77,700
+2,700
| +4% | +$116K |
|
262
Vulcan Materials
VMC
$39B
| $3.32M | 0.01% |
23,027
-293,407
| -93% | -$42.3M |
|
|
XYZ
263
Block, Inc.
XYZ
$45.7B
| $3.3M | 0.01% |
52,664
-90,925
| -63% | -$5.69M |
|
264
Cisco
CSCO
$264B
| $3.2M | 0.01% |
66,725
| – | – |
|
265
Pfizer
PFE
$141B
| $3.14M | 0.01% |
84,480
| – | – |
|
266
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $3.11M | 0.01% |
+40,796
| New | +$3.11M |
|
267
Thor Industries
THO
$5.94B
| $3.1M | 0.01% |
+41,787
| New | +$3.1M |
|
268
Blackrock
BLK
$170B
| $3.06M | 0.01% |
6,086
-187
| -3% | -$94K |
|
269
Hexcel
HXL
$5.16B
| $3.04M | 0.01% |
41,485
-1,335
| -3% | -$97.9K |
|
270
Altria Group
MO
$112B
| $2.99M | 0.01% |
59,804
+5
| +0% | +$250 |
|
271
Costco
COST
$427B
| $2.97M | 0.01% |
10,100
-4,130
| -29% | -$1.21M |
|
272
Strategy Inc Common Stock Class A
MSTR
$95.2B
| $2.83M | 0.01% |
198,250
-88,100
| -31% | -$1.26M |
|
273
Blackstone
BX
$133B
| $2.78M | 0.01% |
49,690
-31
| -0.1% | -$1.73K |
|
274
Edwards Lifesciences
EW
$47.5B
| $2.75M | 0.01% |
35,364
+30,600
| +642% | +$2.38M |
|
275
Bio-Rad Laboratories Class A
BIO
$8B
| $2.71M | 0.01% |
7,320
+3,320
| +83% | +$1.23M |
|